Hemogenyx Pharmaceuticals PLC Announces Half-Year Report

September 30, 2021 3:00 AM

Interim Results for the period ended 30 June 2021LONDON, UK / ACCESSWIRE / September 30, 2021 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the StandardListed biopharmaceutical group developing therapies designed to transform blood disease treatment, announces unaudited interim results for the six-month period ended 30 June 2021.All financial amounts are stated in GBP British pounds unless otherwise indicated.Key HighlightsCompleted development...

Read more

Pressure BioSciences Announces Forward Integration Plans for Ultra Shear Technology Demonstration and Toll Manufacturing Partnerships on U.S. West and East Coasts

September 29, 2021 9:35 AM

Company Flooded with Opportunities to Demo Breakthrough UST Nanoemulsion Benefits and Serve Toll Production Demand in Pharmaceutical, Nutraceutical, and Personal Care ApplicationsSOUTH EASTON, MA / ACCESSWIRE / September 29, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide...

Read more

Applied UV Announces Acquisition of the Assets of KES Science & Technology

September 29, 2021 7:00 AM

Transaction significantly scales air purification product portfolio and customer baseDeveloped for NASA as a patented pathogen killing technology; patents were originally obtained by KESExpands access to food distribution, grocery chains, and fast-growing cannabis marketProprietary photocatalytic oxidation process thoroughly destroys viruses (including COVID-19), bacteria, spores, and fungiAccelerates the strategy to grow revenues through...

Read more

EV Biologics Updates on NFT Minting

September 28, 2021 9:00 AM

NASHVILLE, TN / ACCESSWIRE / September 28, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders with further details about its NFT and minting progress.Our NFT team has been minting the NFT, designated rEVerie, on the Ghostmarket.io platform, with an estimated completion date this week. The Company will mint 72,253 NFTs on this platform for distribution as a dividend. To our knowledge, this is single biggest NFT minting in...

Read more

Black Bird Biotech Announces Important Wide-Ranging Field Tests of its Disruptive MiteXstreamTM Biopesticide by A Second International Agri-Chemical Distributor Based in the Middle East

September 28, 2021 8:30 AM

FLOWER MOUND, TX / ACCESSWIRE / September 28, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstreamTM biopesticide, today announced that an international agri-chemical distributor based in the Middle East is scheduled to begin field testing MiteXstreamTM in October 2021, on numerous crops, including tomato, cucumber, eggplant and leafy greens, as mite populations rise. This distributor noted that, due to the...

Read more

ITOCO Enhances Its Carbon Credit Potential by Increasing Nopal Cactus Plantation Land Areas Under Contract by 40% to a Total of 1,450 Hectares

September 28, 2021 8:00 AM

TORONTO, ON / ACCESSWIRE / September 28, 2021 / ITOCO INC. (OTC PINK:ITMC) is pleased to have received final signatures on an additional 436 hectares of Nopal Cactus Plantations in State of Mexico and Hidalgo State, Mexico from 125 additional farmers.As before, ITOCO has applied to "Verra Standard (VCS)" for the certification of approximately US $750k in Carbon Credits based on the extractive properties of the Nopal Cactus plant vis a vis Carbon...

Read more

Pressure BioSciences to Update Investors on Recent Accomplishments, Year-End Goals, Plans for Accelerating Revenue Growth, and Path to Profitability in 2022

September 28, 2021 7:31 AM

Company to Present this Week at the Benzinga Healthcare and Emerging Growth Small Cap ConferencesSOUTH EASTON, MA / ACCESSWIRE / September 28, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food...

Read more

CB Scientific, Inc. (CBSC) Announces the Launch of Direct-to-Consumer Heart Wellness Check-Up Program in Bangkok, Thailand

September 28, 2021 6:00 AM

Mango Wellness Co., Ltd. and My Cardia Thailand Co., Ltd. to begin new remote cardiac monitoring service through pharmacies and clinics in the greater Bangkok market.ESCONDIDO, CA / ACCESSWIRE / September 28, 2021 / CB Scientific. Inc. (OTC PINK:CBSC) ("CBSC" or the "Company"), a provider of remote ECG cardiac monitoring products and services (my-Cam™ monitor and my-Cardia™ cloud-based software portal), both domestically and...

Read more

Dermata Therapeutics, Inc. Reports Second Quarter 2021 Financial Results and Provides Corporate Update

September 27, 2021 4:01 PM

- Completed oversubscribed $18 million Initial Public Offering (IPO) -- Set to announce topline results from its DMT310 Phase 1b proof of concept (POC) study in mild to moderate psoriasis in 4Q 2021 -- On track to initiate DMT310 Phase 2 study for moderate to severe rosacea in 4Q 2021 -SAN DIEGO, CA / ACCESSWIRE / September 27, 2021 / Dermata Therapeutics, Inc. (Nasdaq:DRMA) ("Dermata" or the "Company"), a clinical-stage biotechnology company...

Read more

Mosaic ImmunoEngineering Announces Keynote Presentation Highlighting its Modular Vaccine Platform Delivery Technology

September 27, 2021 8:55 AM

- Presentation highlighted potential of polymer-based delivery system for slow-release of vaccines that potentially require no booster shots -- Delivery system is transportation and storage friendly with no refrigeration or freezing requirements -NOVATO, CA / ACCESSWIRE / September 27, 2021 / Mosaic ImmunoEngineering Inc. ("Mosaic" or the "Company"), (OTCQB:CPMV), a development-stage biotechnology company focused on bridging immunology and...

Read more

Hancock Jaffe to Participate in the Duologue Series Virtual Webinar Hosted by Ladenburg Thalmann

September 24, 2021 9:00 AM

Live webinar followed by Q&A on Monday, September 27th at 1:00 PM ET with Robert Berman Chief Executive Officer of Hancock Jaffe LaboratoriesIRVINE, CA / ACCESSWIRE / September 24, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) ("Hancock Jaffe" or the "Company"), a medical device company focused on improving the standard of care in the treatment of venous disease, today announced that Robert Berman, CEO of Hancock Jaffe will...

Read more

Applied UV Declares Monthly Preferred Stock Dividend

September 24, 2021 8:30 AM

MOUNT VERNON, NY / ACCESSWIRE / September 24, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced its Board of Directors has authorized the cash dividend to holders of...

Read more

Mosaic ImmunoEngineering Announces Publication of Data Supporting the Potential of Its SARS-CoV-2 Vaccine Candidates under its Modular Vaccine Platform

September 23, 2021 9:00 AM

Vaccine candidates triggered high production of neutralizing antibodies against SARS-CoV-2 and SARS-CoV-1 in preclinical studiesEpitopes used in the vaccine candidates are located in regions that are not known to be susceptible to mutations, including the SARS-CoV-2 Delta VariantThe vaccine candidates are stable at room temperature and can be administered using the Company's MVP technology eliminating the need for multiple dosesNOVATO, CA /...

Read more

The Future Of Personalized Medicine For Mental Illness by Dr. Riyad Domingo

September 23, 2021 8:30 AM

CAPE TOWN, SA / ACCESSWIRE / September 23, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("WGG'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update:Newly appointed Chief Innovation Officer of M2Bio Sciences, Dr. Riyad Domingo, will present his inaugural webinar on the future of mental health therapeutics derived from the psychedelic...

Read more

CB Scientific, Inc. (CBSC) enters into a Consultant Services Agreement with the Dorchester Group LLC

September 23, 2021 6:00 AM

ESCONDIDO, CA/ ACCESSWIRE/ September 23, 2021 / CB Scientific. Inc. (OTC PINK:CBSC) ("CBSC" or the "Company"), a provider of remote cardiac monitoring products and services (my-Cam™ monitor and my-Cardia™ cloud-based software portal), both domestically and internationally, today announced that it has hired and enter into a consultant services agreement with the Dorchester Group LLC, and its President Robert H. Hesse, to assist and...

Read more

Notice of Extra General Meeting in Biovica International AB

September 23, 2021 2:20 AM

UPPSALA, SE / ACCESSWIRE / September 23, 2021 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II)The shareholders of Biovica International AB, reg. no. 556774-6150, (the "Company") are hereby invited to the extra general meeting on Tuesday 12 October 2021.Information with respect to the coronavirus The Company is mindful of the health and well-being of its shareholders and employees. It´s important for the Company to take...

Read more

Viewpoint Molecular Targeting(R) Announces Publication of Preclinical Data of VMT01 in Peer-Reviewed Journal, "Cancers"

September 22, 2021 10:00 AM

Viewpoint advancing new, proprietary class of personalized 212 Pb-based alpha-particle radiopharmaceuticals to transform the treatment landscape of radiotherapies for cancerPositive preclinical data have demonstrated that a single dose of [212 Pb]VMT01 has significantly arrested melanoma tumor growth and extended survivalThe combination of [212 Pb]VMT01 and immune checkpoint inhibitors produced a 43% complete and durable response rate in this...

Read more

Hancock Jaffe Announces Corporate Rebranding to Reflect Prioritization of its Development Pipeline on Venous Disease Programs

September 21, 2021 4:00 PM

- Hancock Jaffe changing name to enVVeno Medical Corporation and ticker symbol to NASDAQ: NVNO, effective October 1, 2021 -- Development strategy to focus on venous disease and advancement of the VenoValve® -- Initiated development of second product for the treatment of venous disease; expected to be unveiled in mid-2022 -- Management to host a conference call with live video webcast at 4:30 p.m. ET today, September 21st -IRVINE, CA /...

Read more

Black Bird Biotech Seeks Approval in All Remaining States, to Open Up Entire US Market, Including the Projected $45 Billion Cannabis Industry, for its Disruptive Plant-Based MiteXstreamTM Biopesticide Sales Efforts

September 21, 2021 8:30 AM

FLOWER MOUND, TX / ACCESSWIRE / September 21, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstreamTM biopesticide, today announced that, on the heels of its first sales of its game-changing biopesticide, MiteXstreamTM, it is seeking approval of MiteXstreamTM in the remaining 35 states and in D.C. to more readily provide much-needed crop protection, both indoor and outdoor, to the dynamic cannabis industry, one...

Read more

Dermata to Present Results from its DMT410 Phase 1b Proof of Concept Aesthetic Study at The American Society for Dermatologic Surgery (ASDS) 2021 Annual Meeting

September 21, 2021 8:00 AM

The presentation will highlight efficacy and safety data from a Phase 1b proof of concept study evaluating one application of DMT410 as a new topical intradermal delivery mechanism of botulinum toxin for multiple aesthetic skin conditionsSAN DIEGO, CA / ACCESSWIRE / September 21, 2021 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"), a clinical-stage biotechnology company focusing on the treatment of medical...

Read more